Pages that link to "Q28208680"
Jump to navigation
Jump to search
The following pages link to Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung (Q28208680):
Displaying 50 items.
- Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy (Q21198871) (← links)
- A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor mediating CDKN1A (p21WAF1/CIP1) degradation (Q24306061) (← links)
- SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis (Q24316768) (← links)
- AMPK phosphorylation of raptor mediates a metabolic checkpoint (Q24329244) (← links)
- Molecular biology of lung cancer (Q24606677) (← links)
- Molecular biology of lung cancer: clinical implications (Q24610335) (← links)
- Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors (Q24614112) (← links)
- A census of human cancer genes (Q24647081) (← links)
- Somatic mutations affect key pathways in lung adenocarcinoma (Q24648102) (← links)
- Characterizing the cancer genome in lung adenocarcinoma (Q24649926) (← links)
- Amino acid management in cancer (Q26798087) (← links)
- Targeting LKB1 in cancer - exposing and exploiting vulnerabilities (Q26801412) (← links)
- AMPK as a potential anticancer target - friend or foe? (Q26829427) (← links)
- AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function (Q26865723) (← links)
- Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer. (Q27853286) (← links)
- Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases (Q28085339) (← links)
- Genomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFR (Q28086993) (← links)
- (Q28176058) (redirect page) (← links)
- PCK2 activation mediates an adaptive response to glucose depletion in lung cancer (Q28235954) (← links)
- Comprehensive molecular profiling of lung adenocarcinoma (Q28244995) (← links)
- STE20-related kinase adaptor protein α (STRADα) regulates cell polarity and invasion through PAK1 signaling in LKB1-null cells (Q28264138) (← links)
- Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing (Q28275103) (← links)
- Filamin A phosphorylation by Akt promotes cell migration in response to arsenic (Q28397930) (← links)
- Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer (Q28550689) (← links)
- Investigation of LKB1 Ser431 phosphorylation and Cys433 farnesylation using mouse knockin analysis reveals an unexpected role of prenylation in regulating AMPK activity (Q28591614) (← links)
- Patterns of somatic mutation in human cancer genomes (Q29547841) (← links)
- The LKB1-AMPK pathway: metabolism and growth control in tumour suppression (Q29617506) (← links)
- AMP-activated protein kinase regulates CO2-induced alveolar epithelial dysfunction in rats and human cells by promoting Na,K-ATPase endocytosis (Q30481019) (← links)
- Integrin-binding protein nischarin interacts with tumor suppressor liver kinase B1 (LKB1) to regulate cell migration of breast epithelial cells (Q30540204) (← links)
- LKB1 loss in melanoma disrupts directional migration toward extracellular matrix cues. (Q30596293) (← links)
- Local alignment vectors reveal cancer cell-induced ECM fiber remodeling dynamics. (Q30833586) (← links)
- Mapping tumor-suppressor genes with multipoint statistics from copy-number-variation data (Q31044207) (← links)
- AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma (Q31158130) (← links)
- Spectrum of LKB1, EGFR, and KRAS mutations in chinese lung adenocarcinomas (Q33563803) (← links)
- Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells (Q33572423) (← links)
- No association between promoter polymorphism of STK11 gene and lung cancer risk in the Korean population (Q33576271) (← links)
- Enhancing mTOR-targeted cancer therapy (Q33604979) (← links)
- Molecular pathways and therapeutic targets in lung cancer (Q33688872) (← links)
- Amplification of chromosomal segment 4q12 in non-small cell lung cancer (Q33708516) (← links)
- Homozygous deletion of the STK11/LKB1 locus and the generation of novel fusion transcripts in cervical cancer cells (Q33721668) (← links)
- AMPK as a metabolic tumor suppressor: control of metabolism and cell growth (Q33789079) (← links)
- Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab (Q33877467) (← links)
- C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma (Q34031219) (← links)
- Gene expression of the tumour suppressor LKB1 is mediated by Sp1, NF-Y and FOXO transcription factors (Q34193241) (← links)
- LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling (Q34279063) (← links)
- The LKB1 tumor suppressor controls spindle orientation and localization of activated AMPK in mitotic epithelial cells (Q34345692) (← links)
- Recent progress on liver kinase B1 (LKB1): expression, regulation, downstream signaling and cancer suppressive function (Q34358845) (← links)
- FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop (Q34359607) (← links)
- LKB1, the multitasking tumour suppressor kinase (Q34553801) (← links)
- STRAD in Peutz-Jeghers syndrome and sporadic cancers. (Q34561256) (← links)